Functional magnetic resonance imaging;
Drug development;
Anxiety;
Pharmacology;
Biomarkers;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
In this review, we survey the state of the field of functional magnetic resonance imaging (fMRI) as it relates to drug discovery and drug development. We highlight the advantages and limitations of fMRI for this purpose and suggest ways to improve the use of fMRI for developing new therapeutics, with emphasis on treatments for anxiety disorders. Fundamentally, pharmacological studies with standard psychiatric treatments using standardized behavioral probes during fMRI will need to be carried out to determine characteristic brain signatures that could be used to predict whether novel compounds are likely to have specific therapeutic effects.
机构:
Denver VA Med Ctr, Res Serv, Denver, CO 80220 USA
Univ Colorado, Dept Psychiat, Aurora, CO USA
Univ Colorado, Neurosci Program, Aurora, CO USADenver VA Med Ctr, Res Serv, Denver, CO 80220 USA
Smucny, Jason
Wylie, Korey P.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Colorado, Dept Psychiat, Aurora, CO USADenver VA Med Ctr, Res Serv, Denver, CO 80220 USA
Wylie, Korey P.
Tregellas, Jason R.
论文数: 0引用数: 0
h-index: 0
机构:
Denver VA Med Ctr, Res Serv, Denver, CO 80220 USA
Univ Colorado, Dept Psychiat, Aurora, CO USA
Univ Colorado, Neurosci Program, Aurora, CO USADenver VA Med Ctr, Res Serv, Denver, CO 80220 USA
机构:
Merck & Co Inc, Discovery Neurosci Res, West Point, PA USAHarvard Univ, McLean Hosp, Sch Med, Ctr Pain & Brain,Brain Imaging Ctr, Belmont, MA 02478 USA